Return to homepagePandemic Pact

Development of a genetically attenuated vaccine candidate against SARS-CoV-2

Grant number: VLTTI20265

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2020

  • Known Financial Commitments (USD)

    $87,232

  • Funder

    Estonian Research Council

  • Principal Investigator

    Andres Merits

  • Research Location

    Estonia

  • Lead Research Institution

    University of Tartu, Department of Natural and Exact Sciences, Institute of Technology

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

A research group led by Andres Merits, Professor of Applied Virology at the University of Tartu, is participating in a project to develop a vaccine against the COVID-19 virus. The project is coordinated by Griffith University, Australia, in partnership with Indian Immunologicals Limited, a leading vaccine developer.